Citi Pharma Limited (PSX:CPHL)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
61.66
-0.38 (-0.61%)
At close: Oct 16, 2026

Citi Pharma Cash Flow Statement

Millions PKR. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
790.33892.04833.46657.98653.69
Depreciation & Amortization
206.04168.09138.2290.5976.83
Loss (Gain) From Sale of Investments
-0.232.79-29.2835.124.48
Provision & Write-off of Bad Debts
11.262.24.78--
Other Operating Activities
-15.71-79.1955.33-26.27136.33
Change in Accounts Receivable
-403.27-885.74-282.69-480.58-957.02
Change in Inventory
215.95-726.33-594.39-917.35-913.44
Change in Accounts Payable
-406.96227.321,359260.08782.19
Change in Other Net Operating Assets
-235.3578.13-146.7951.42-106.03
Operating Cash Flow
162.06-320.71,338-329-322.97
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-706.69-150.06-568.2-954.47-600.46
Investment in Securities
63.3442.3152.83179.77-312.12
Other Investing Activities
--5.233.43-6.13-8.91
Investing Cash Flow
-643.34-112.98-511.94-780.83-921.48

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
6.381,470-1,246509.37
Long-Term Debt Issued
113.66---300
Total Debt Issued
120.051,470-1,246809.37
Short-Term Debt Repaid
-5.69-37.73-331.54--
Long-Term Debt Repaid
-32.18-45.15-56.17-383.24-148.3
Lease Payments
-32.18-32.29---
Total Debt Repaid
-37.87-82.89-387.7-383.24-148.3
Net Debt Issued (Repaid)
82.181,387-387.7863.24661.07
Common Dividends Paid
-800.24-739.82-571.15--311.54
Other Financing Activities
--0.58---521.38
Financing Cash Flow
-718.06646.82-958.86863.24-171.85

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Miscellaneous Cash Flow Adjustments
-0----
Net Cash Flow
-1,199213.14-133.2-246.58-1,416

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-544.63-470.77769.4-1,283-923.43
Free Cash Flow Growth
-----
Free Cash Flow Margin
-3.87%-3.58%6.20%-10.35%-9.44%
Free Cash Flow Per Share
-2.38-2.063.37-5.62-4.07
Levered Free Cash Flow
-437.2-567.3446.95-1,324-1,497
Unlevered Free Cash Flow
-203.09-368.76631.59-1,240-1,461
Free Cash Flow After Leases
-576.81-503.06769.4-1,283-923.43

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
393.4356.83289.99329.358.73
Cash Income Tax Paid
624.71574461.13367.92309.61
Change in Working Capital
-829.64-1,307335.09-1,086-1,194